13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 84 holding rows worth $128,479,667.
- Accession
- 0001104659-25-049125
- Filer
- CIK 1274413
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 84 entries on the cover page, a total value of $128,479,667 stated on the cover page (in dollars after the unit check, H1), rows summing to $128,479,667 with VALUE read as dollars as filed, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LENZ THERAPEUTICS INC | 52635N103 | COM | 977,245 | $25,124,969 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 9,416 | $7,776,769 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 12,895 | $6,753,756 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 370,513 | $5,883,746 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 800,787 | $5,589,493 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 21,800 | $3,615,312 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 32,020 | $3,587,841 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 10,385 | $3,235,447 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 14,800 | $3,100,896 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 5,250 | $2,600,168 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 18,698 | $2,480,290 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 24,226 | $2,443,919 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 26,900 | $2,414,544 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 4,725 | $2,290,775 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 6,100 | $2,270,725 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 10,575 | $2,167,875 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 23,850 | $2,143,161 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 3,103 | $1,836,557 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 2,773 | $1,758,720 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 23,530 | $1,663,336 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 3,250 | $1,617,200 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 17,175 | $1,563,956 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 59,650 | $1,511,531 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 5,205 | $1,405,454 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 18,790 | $1,381,065 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 69,240 | $1,335,640 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 100,205 | $1,260,579 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 35,965 | $1,220,292 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 9,000 | $1,210,500 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 19,500 | $1,189,305 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 15,230 | $1,161,897 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 25,325 | $1,117,592 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 29,920 | $1,081,309 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 678,574 | $1,024,647 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 15,000 | $1,024,350 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 11,235 | $994,410 | dollars as filed | |
| RADNET INC | 750491102 | COM | 20,000 | $994,400 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 17,250 | $886,133 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 107,585 | $877,894 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 34,000 | $869,040 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 68,500 | $837,755 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 2,927 | $796,642 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 21,040 | $794,470 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 18,068 | $726,153 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 4,000 | $699,960 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 28,348 | $680,919 | dollars as filed | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 183,000 | $656,970 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 1,500 | $652,440 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 57,550 | $610,030 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 15,108 | $590,270 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 33,695 | $583,260 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 16,085 | $556,058 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 81,800 | $514,522 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 48,907 | $493,472 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 79,020 | $473,330 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 8,350 | $425,516 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 2,855 | $390,678 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 6,145 | $372,080 | dollars as filed | |
| iShares 0-3 Month Treasury Bond ETF | 46436E718 | SHS | 3,589 | $361,323 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,091 | $325,903 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 2,905 | $321,293 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 44,383 | $296,035 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 3,682 | $292,130 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 9,280 | $288,886 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 9,440 | $284,805 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 2,274 | $282,317 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 730 | $241,798 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 765 | $235,827 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 6,240 | $220,646 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 26,870 | $210,930 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 2,850 | $197,904 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 5,710 | $191,513 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 10,090 | $186,564 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 19,800 | $172,458 | dollars as filed | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 531 | $161,790 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 5,600 | $158,760 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,020 | $118,963 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 20,000 | $111,600 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 2,160 | $104,198 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 95,000 | $103,550 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 12,930 | $90,769 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 2,540 | $86,436 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 11,500 | $60,835 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 11,700 | $52,416 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-049125 | this filing | 2025-05-15 | acceptance time not in the bulk data set |